Health stocks hit after Trump taps RFK Jr for top job
Shares in vaccine makers and healthcare firms around the world slid sharply on Friday, as investors warned that Donald Trump's choice of Robert F Kennedy Jr as US Health Secretary could pose new challenges to the sector.
Kennedy is known as a vaccine sceptic and, if confirmed in the post, has vowed to use it to crack down on “Big Pharma”.
The news prompted a sell-off across the industry. In the US, shares in Pfizer sank more than 4% and Moderna about 7% while UK-listed firms AstraZeneca and GSK dropped more than 3%.
Previous to this pick, stocks in the green energy market (solar and wind) took big hits as well. FSLR, (the premium solar energy company) went from $233 to $171 (27% drop in price) the day after Trump was announced as the winner. VWDRY (a wind energy company) went from $6.50 to $4.60 (30% drop in price) over the next week after the announcement was made.
Healthcare and clean energy are the future of this country and the drops in price suggest that in those areas, Trump is not seen as a plus but as a minus
